Dr. Ali-Osman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
16601 N 40th St
Ste 204
Phoenix, AZ 85032Phone+1 602-633-3722Fax+1 602-953-5466
Education & Training
- University of Texas Southwestern Medical CenterFellowship, Surgical Critical Care, 2011 - 2012
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Surgery, 2008 - 2011
- The University of Texas Health Science Center at San AntonioPost-Doctoral Fellowship, 2006 - 2008
- The University of Texas Health Science CenterGraduate coursework, 2006 - 2008
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineResidency, Surgery, 2004 - 2006
- University of Texas Health Science Center San Antonio Joe and Teresa Lozano Long School of MedicineInternship, Surgery, 2004 - 2005
- The University of Texas Health Science Center at San AntonioClass of 2004
- University of TexasBA, Microbiology, 1994 - 1999
- University of Texas Southwestern Medical CenterFellowship, Surgical Critical Care
Certifications & Licensure
- AZ State Medical License 2013 - 2027
- TX State Medical License 2012 - 2018
- American Board of Surgery Surgery
- American Board of Surgery Surgical Critical Care
Awards, Honors, & Recognition
- Regional Competition 1st place Clinical Presentation American College of Surgeons Committee on Trauma, 2012
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
- 1st place Department of Surgery University of Texas Health Science Center, San Antonio, TX, 2008
- Join now to see all
Publications & Presentations
PubMed
- 8 citationsSurgical stabilization versus nonoperative treatment for flail and non-flail rib fracture patterns in patients with traumatic brain injury.Jonne T H Prins, Esther M M Van Lieshout, Francis Ali-Osman, Zachary M Bauman, Eva-Corina Caragounis
European Journal of Trauma and Emergency Surgery. 2022-08-01 - 16 citationsEuropean genetic ancestry associated with risk of childhood ependymomaChenan Zhang, Quinn T. Ostrom, Helen M. Hansen, Julio Gonzalez-Maya, Donglei Hu
Neuro-Oncology. 2020-11-26 - 4 citationsInvasive fungal wound infection in an otherwise healthy trauma patient (Mucor Trauma).Whitney Wilson, Francis Ali-Osman, Joseph F. Sucher, Gina R. Shirah, Alicia Mangram
Trauma Case Reports. 2019-11-20
Journal Articles
- Silencing of CCR2 Inhibits the Progression of Nephropathy in a Type II Diabetic Mouse Model.Ali-Osman F. Lentiviral, Journal of Surgical Research Vol. 144
Abstracts/Posters
- Use of RNA Interference in Gene Regulation in a Mouse Model.J. Bradley Aust, Surgical Society Annual Meeting, San Antonio, TX
- Does Genetic Inactivation of CCR2 Offer Protection from Progressive Renal Disease in a Type II Diabetic Mouse Model?J. Bradley Aust, Surgical Society Annual Meeting, San Antonio, TX
Lectures
- The Role of Thromboelastography in Assessing the Hemostatic Profile in Traumatic Brain Injury.University of Texas Southwestern Medical Center, Dallas, TX
- Management of Ingested Razor Blades.University of Texas Southwestern Medical Center, Dallas, TX
- Early Non-Bronchoscopic Broncho-Alveolar Lavage (screening-BAL): Predictor of Ventilator-Associated Pneumonia (VAP) in Neuro -Trauma Patients?University of Texas Southwestern Medical Center, Dallas, TX
- Join now to see all
Press Mentions
- Highly Respected Trauma Surgeon, Francis Ali-Osman, MD Will Be Featured in the Leading Physicians of the WorldFebruary 15th, 2018
Grant Support
- P53-Dependent GSTP1 Gene Regulation And Glioma Drug ResistanceNational Cancer Institute2010–2012
- Experimental TherapeuticsNational Cancer Institute2005–2012
- Protein Kinase C And GSTP1 Interactions In Glioma Drug ResistanceNational Cancer Institute2008–2011
- Novel Targeted Therapeutics For Cental Nervous System MalignanciesNational Cancer Institute2007–2010
- Rational Development Of Gstp1-Targeted Anti-Glioma TherapeuticsNational Cancer Institute2007–2008
- DNA Methylation And GSTP1 Gene Regulation In GliomasNational Cancer Institute2002–2007
- Novel Targeted Therapeutics For CNS MalignanciesNational Cancer Institute2006
- Development Of Gstp1-Targeted Anti-Glioma TherapeuticsNational Cancer Institute2004–2006
- GSH Transferase PI Polymorphism And Drug ResistanceNational Cancer Institute1999–2003
- DNA Methylation And GSTP1 Gene Regulation In GliomasNational Cancer Institute2002
- Pediatric Oncology Research Training ProgramNational Cancer Institute1998–2001
- DNA Damage As Predictor Of Clinical Response In MelanomaNational Cancer Institute1998–1999
- DNA Repair In Biochemotherapy Of MelanomaNational Cancer Institute1994–1997
- Glutathione Transferases In Nitrosourea-Resistant GliomaNational Cancer Institute1992–1994
- Glutathione In Brain Tumor Resistance To NitrosoureasNational Cancer Institute1991–1992
- Glutathione In Brain Tumor Resistance To NitrosoureasNational Cancer Institute1988–1990
- In Vitro Antineoplastic Drug Toxicology CharacterizationDivision Of Cancer Treatment1985
- Cloning Of Human Tumor Cells In Tissue Culture SystemsDivision Of Cancer Treatment1985
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: